跳至主要内容
临床试验/KCT0000530
KCT0000530尚未招募未知

The effect of botulinum toxin-A(BTX-A) injection for equinovarus deformity in children with unilateral cerebral palsy.

Yonsei University Health System, Severance Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
2(Year) 至 18(Year)(—)
性别
All

入选标准

  • ? Cerebral palsy, spastic hemiplegia (age: 2~18 years)
  • ? dynamic equinovarus foot deformity
  • ? The patient able to independent gait (GMFCS classification I, II, III)
  • ? ankle spasticity more than modified Ashworth scale grade 1
  • ? the patient with himself and his legal guardian signed the consent form with voluntary participation.

排除标准

  • ? The botulinum toxin injections within 3 months before the start of the study
  • ? Neurosurgery, orthopedic surgery within 3 months before the start of the study, or scheduled within study duration.
  • ? Previous history like hypersensitivity for botulinum toxin
  • ? Severe athetoid cerebral palsy
  • ? Participate in other clinical trial
  • ? Likely to conceive
  • ? Take prohibited drugs to combination, and not able to stopped
  • -muscle relaxant: tubocurarine chrolide , sodium dantrolate, baclofen, etc.
  • -Spectinomycin HCl
  • -Aminoglycosides : Gentamicin sulfate, Neomycin sulfate, etc
  • -Polypeptides: Polymyxin B sulfate, etc
  • -Tetracycline
  • -lincosamides
  • -Anticholinergics: scopolamine butylbromide, trihexyphenidyl HCl, etc
  • -Benzodiazepines or similar drugs: : diazepam, etizolam
  • ? Judged to be unsuitable in this study

研究者

相似试验